EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long-term outcomes of catheter ablation in atrial fibrillation patients: the impact of changed CHA2DS2-VASc scores

Mingjie Lin, Mei Li, Xinyan Yang, Juntao Wang, Bing Rong, Kai Zhang, Tongshuai Chen, Wenqiang Han, Jingquan Zhong

Frontiers in Cardiovascular Medicine · 18.11.2026 · 13

DOI: 10.3389/fcvm.2026.1949346 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 18.11.2026. Verfasst von Mingjie Lin und 8 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Catheter ablation is widely utilized for atrial fibrillation (AF) management, yet long-term recurrence remains challenging. It is critical to understand how cardiovascular comorbidities, as captured by the CHA 2 DS 2 -VASc score, affect AF recurrence and major adverse cardiovascular and cerebrovascular events (MACCE) after ablation.

Methods

This analysis used data from a prospectively maintained, single-center observational registry (ChiCTR-OCH-14004674) involving 1,685 patients who underwent AF catheter ablation between January 2015 and December 2019. The relationship between longitudinal (time-updated) CHA 2 DS 2 -VASc score changes and AF recurrence and MACCE was examined with time-to-event methods.

Results

Over the course of a 58.1 ± 17.1-month follow-up period, the CHA 2 DS 2 -VASc score rose from 1.84 ± 1.35 to 3.10 ± 1.44. AF recurrence was observed in 442 patients (26.2%). Patients with a changed CHA 2 DS 2 -VASc score demonstrated a higher incidence of AF recurrence (hazard ratio [HR] and 95% Confidence Interval [CI]: 1.552 (1.398–1.724), p < 0.001) and MACCE post-ablation (HR [95%CI]: 4.90 (3.21–7.50)). In a time-updated Cox model that used only information available before each event, this association persisted (AF recurrence HR [95% CI]: HR 4.98 (3.87–6.40) unadjusted; 5.48 (4.22–7.10) adjusted for age, sex and baseline CHA₂DS₂-VASc). Multivariable analyses identified an increasing CHA 2 DS 2 -VASc score, along with new-onset comorbidities such as diabetes, hypertension, and vascular disease, as significant predictors of AF recurrence. An increased CHA 2 DS 2 -VASc score was also markedly associated with the elevated MACCE risk. Notably, crossing an age threshold itself was not independently associated with recurrence; the prognostic signal was carried by incident non-age comorbidities rather than by aging per se.

Discussion

A changed CHA 2 DS 2 -VASc score serves as a dynamic and salient marker for AF recurrence and MACCE following AF ablation. Our findings highlight the importance of vigilant monitoring and management of cardiovascular risk factors in post-ablation patients.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Lin, M., Li, M., Yang, X., Wang, J., Rong, B., Zhang, K., Chen, T., Han, W., & Zhong, J. (2026). Long-term outcomes of catheter ablation in atrial fibrillation patients: the impact of changed CHA2DS2-VASc scores. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1949346

Vancouver

Lin M, Li M, Yang X, Wang J, Rong B, Zhang K, et al. Long-term outcomes of catheter ablation in atrial fibrillation patients: the impact of changed CHA2DS2-VASc scores. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1949346

BibTeX
@article{Lin2026,
  author = {Lin, Mingjie and Li, Mei and Yang, Xinyan and Wang, Juntao and Rong, Bing and Zhang, Kai and Chen, Tongshuai and Han, Wenqiang and Zhong, Jingquan},
  title = {Long-term outcomes of catheter ablation in atrial fibrillation patients: the impact of changed CHA2DS2-VASc scores},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1949346}
}
Kostenlos starten →